This paper is in the following e-collection/theme issue:

Dermatology (47) Ophthalmology (48) Dermatology Health Services Research (51)

Published on in Vol 8, No 4 (2019): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15218, first published .
Dermatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study

Dermatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study

Dermatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study

Authors of this article:

Nouf Talal Mleeh1 Author Orcid Image ;   Nujood Abdulwahed Alzahrani1 Author Orcid Image ;   Jehad Osama Hariri1 Author Orcid Image ;   Hatan Hisham Mortada2 Author Orcid Image ;   Mohammed Ridha Algethami2 Author Orcid Image
Article Authors Cited by (4) Tweetations (8) Metrics

Journals

  1. Murtagh P, Murphy M, Smyth A, McElnea E, Fahy G. Improving ophthalmic screening for hydroxychloroquine associated retinopathy. Expert Review of Ophthalmology 2021;16(2):133 View
  2. Fett N, Werth V. A Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials. JAMA Dermatology 2021;157(9):1112 View
  3. Somisetty S, Santina A, Sarraf D, Mieler W. The Impact of Systemic Medications on Retinal Function. Asia-Pacific Journal of Ophthalmology 2023;12(2):115 View
  4. Alghamdi A, AlQefari G, Alduraibi K, Al-Amer M, Alharbi B, Alqefari A, Alqifari H, Alhameedy M. Dermatologists’ and Rheumatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study. Cureus 2024 View